Your browser doesn't support javascript.
loading
Analysis of metabolome changes in the HepG2 cells of apatinib treatment by using the NMR-based metabolomics.
Gu, Jinping; Shu, Dan; Su, Feng; Xie, Yuanyuan; Liang, Xianrui.
  • Gu J; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, PR China.
  • Shu D; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, PR China.
  • Su F; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, PR China.
  • Xie Y; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, PR China.
  • Liang X; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, PR China.
J Cell Biochem ; 120(11): 19137-19146, 2019 11.
Article en En | MEDLINE | ID: mdl-31264262

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridinas / Resonancia Magnética Nuclear Biomolecular / Metaboloma / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridinas / Resonancia Magnética Nuclear Biomolecular / Metaboloma / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article